Ignite Creation Date:
2024-05-05 @ 11:51 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00154778
Status:
COMPLETED
Last Update Posted:
2007-07-31
First Post:
2005-09-08
Brief Title:
TaxolPaclitaxelUFT and Leucovorin in Patients With Advanced Gastric Cancer
Sponsor:
National Taiwan University Hospital
Organization:
National Taiwan University Hospital
Study Overview
Official Title:
An OpenMulti-CenterPhase II Clinical Trial tO Evaluate Efficacy and Safety oF TAXOLPACLITAXELUFTand LEUCOVORIN in Patients With Advanced Gastric Cancer
Status:
COMPLETED
Status Verified Date:
2005-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the response rate of Paclitaxel combination chemotherapy with UFT and Leucovorin in patients with advanced gastric cancer
Detailed Description:
Since 1982cancer has been the leading cause of death in Taiwan In particulargastric cancer is the fourth leading cause of death in male cancer patients and the sixth for female patients in 2000accounting for an estimated 2374 deaths In recent years the treatment of gastric cancer patients has gradually been improving due to advances in early diagnosis and surgical techniques Although chemotherapy and radiation therapy have been used in either the adjuvant or palliative setting their values are still limited due to their unacceptable toxicity or inadequate efficiency
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None